Clinical solutions
Clinical Monitoring

Expert clinical monitoring for Australian and New Zealand trials as well as multinational trials

Avance Clinical has experienced clinical monitoring staff across all phases of clinical trials and can collaboratively support the Australian CRO arm of multinational trials.

Fast, nimble, and adaptive solutions

Avance Clinical focuses on servicing biotech clients in their early phases of drug development delivering fast, nimble, and adaptive client-oriented solutions.

Avance Clinical delivers customised solutions designed around specific client needs rather than a one size fits all approach.

Technology

The company has focussed on state-of-the-art technology and systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, and Medrio are just some of the technology partners.

Avance Clinical offers globally accepted data from an established clinical trial ecosystem, that includes world-class PIs and Sites that are able to rapidly access specialized patient groups.

Clinical Monitoring Services

All Avance Clinical trials are monitored in accordance with Australian and New Zealand regulatory requirements and ICH GCP.

Project manager as contact

To ensure the seamless exchange of information each clinical research trial client is assigned a Project Manager as a single point of contact.

Quality assurance

Avance Clinical’s Quality Assurance department audits and reports on the monitoring, collection, and reporting of accurate, precise, and valid data.

SOPs guide trials

Avance Clinical has an extensive suite of SOPs to expertly guide clinical research trial activities. Additionally, Avance Clinical can adapt seamlessly to client SOP and requirements if required.

Regulatory compliance
Integration with Quality Assurance
Compliant with ICH GCP
The Australian Government R&D grant means up to 43.5% rebate on clinical trial spend
Site Initiation Visit (SIV) and Study Start can be achieved in 5 – 6 weeks
No IND required for clinical trials
Clinical Monitoring

Learn more about how we work

Request a Proposal or Talk to our Team  CONTACT US

More benefits

Avance Clinical can leverage all the benefits of Australia and New Zealand’s clinical ecosystem to deliver your study

Almost half clinical costs

The Government R&D grant means up to 43.5% rebate on clinical trial spend

Rapid Start-up

Site Initiation Visit (SIV) and Study Start can be achieved in 5 – 6 weeks

Start-up time

Site Initiation Visit (SIV) and Study Start can be achieved in 5 – 6 weeks

No IND

No IND required for clinical trials

GMP material

Full GMP material is not mandated for Phase I clinical trials

Gene-therapy accreditation

Avance Clinical is an accredited gene-therapy CRO

Seasonal studies

Northern hemisphere Sponsors can conduct their studies year-round by taking advantage of Australia and New Zealand's counter-flu and allergy seasons

FDA and global regulatory data compliance

Major hospitals with world-class infrastructures and dedicated Clinical Trial Units with a long track record in FDA compliant research

Rebate

The Government R&D grant means up to 43.5% rebate on clinical trial spend

Start-up time

Site Initiation Visit (SIV) and Study Start achieved in 5 – 6 weeks

Capabilities

Full service CRO in Australia and New Zealand

195
Studies in the past 5 years
150
Experienced Team Members
10,000
Study Participants (5 years)
24
Years of of CRO experience

“Within Asia-Pacific’s highly competitive CRO market, Avance Clinical stands out as a leader in early phase biotech clinical trials.

The company offers a highly responsive and proactive service for biotechs wanting rapid and innovative clinical trial solutions, with the highest level of data compliance. Avance Clinical offers a real size match for biotechs that means better mission understandings and stronger customer service compared to some of the larger CROs.”

Nidhi JalaliAnalyst Best Practices, Frost & Sullivan

Ready To Partner with Us?

Contact Us